SMITHKLINE BEECHAM PHARMACEUTICALS (SB)
SmithKline Beecham plc is a company focused on pharmaceuticals, biologics, vaccines, and consumer healthcare. It was formed by the merging of Beecham plc and SmithKline Beckman Corporation. It manufactures drugs and vaccines for major disease areas such as asthma, cancer, infections, diabetes, digestive and mental health conditions.It's key selling drugs for mental health conditions were Advair, Avodart, Flovent, Augmentin, Lovaza, and Lamictal for the year 2013. Its consumer healthcare division, which earned £5.2 billion in 2013, sells oral healthcare and nutritional products, drinks and over-the-counter medicines, including Sensodyne, Boost and Horlicks. SmithKline Beecham plc is based in Brentford, London.
SMITHKLINE BEECHAM PHARMACEUTICALS (SB)
Industry:
Biotechnology Health Care Manufacturing
Founded:
1989-01-24
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Status:
Active
Similar Organizations
BioVectra
BioVectra offers contract development and manufacturing capacity for intermediates and active pharmaceutical ingredients.
Current Employees Featured
Founder
More informations about "SmithKline Beecham Pharmaceuticals (SB)"
SmithKline Beecham Pharmaceuticals (SB) - Crunchbase
SmithKline Beecham plc is a company focused on pharmaceuticals, biologics, vaccines, and consumer healthcare. It was formed by the merging of …See details»
GlaxoSmithKline Inc., Mississauga, Ontario - CompanyListing.ca
History and heritage | GSK
In 1989, SmithKline Beckman Corp. merged with Beecham Group plc to form SmithKline Beecham plc. In the mid-1980s, the Wellcome Trust publicly sold shares of the Wellcome …See details»
Home | GSK
At GSK, we unite science, technology and talent to get ahead of disease togetherSee details»
Inside the Glaxo Wellcome and SmithKline merger
May 1, 2001 SB was formed in 1989 through the merger of SmithKline BeckmanCorporation, a Pennsylvania corporation, and Beecham Groupp.l.c., an English public limited company. Its …See details»
SmithKline Beecham Pharmaceuticals (SB) - Funding, Financials ...
SmithKline Beecham Pharmaceuticals (SB) has acquired Omega Pharmaceuticals on Feb 1997. They acquired Omega Pharmaceuticals for $19K. Which types of acquisition does this …See details»
Home | GSK US
GSK US is a leading biopharmaceutical company focusing on vaccines, specialty medicines, and respiratory care.See details»
SmithKline Beecham Pharmaceuticals (SB) - Crunchbase
Organization. SmithKline Beecham Pharmaceuticals (SB) Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Highlights. Employee Profiles 7. …See details»
SmithKline Beecham Ltd - Company Profile and News
SmithKline Beecham Ltd. discovers, develops, manufactures, and markets pharmaceuticals, vaccines, over-the-counter medicines, and health-related consumer products.See details»
GlaxoSmithKline becomes GSK - Fierce Pharma
May 16, 2022 More than two decades ago, Glaxo Wellcome and SmithKline Beecham combined to become GlaxoSmithKline. But as the British Big Pharma looks to slim down its organization with its consumer demerger ...See details»
How SmithKline Beecham Makes Better Resource-Allocation …
In 1993, SmithKline Beecham was spending more than half a billion dollars per year on R&D, the lifeblood of any pharmaceuticals company. Ever since the 1989 merger that created the …See details»
A history of... GlaxoSmithKline - pharmaphorum
2 days ago SmithKline Beecham plc was formed in 1989, following the merger of SmithKline Beckman and the Beecham Group plc.  , "Glaxo’s first pharmaceutical product was the …See details»
SB-210313 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 SB-210313, Initially developed by Smithkline Beecham Pharmaceuticals (India) Ltd., ... Initially developed by Smithkline Beecham Pharmaceuticals (India) Ltd., Now, its global …See details»
SmithKline Beecham Pharmaceuticals (SB) - Crunchbase
SmithKline Beecham plc develops products and services related to pharmaceuticals, biologics, vaccines, and consumer healthcare.See details»
Glaxo Wellcome & SmithKline Beecham merger - updated story
Jan 19, 2000 The new entity, to be called Glaxo SmithKline, is described by the two firms as a merger of equals, though GW shareholders will own 58.75% of the company. GSK's chief …See details»
At a glance | GSK US
Over the last two years we have played a key role to develop treatments and vaccines against COVID. Through a partnership with Vir Biotechnology we have developed, and contracted, …See details»
GlaxoSmithKline Merger - SpringerLink
Nov 30, 2018 The merger of Beecham and SmithKline in the year 1989 sparked a wave of mergers between pharmaceutical mergers in the next decade. SmithKline was facing revenue …See details»
Inside the Glaxo Wellcome and SmithKline merger - Practical Law
SB was formed in 1989 through the merger of SmithKline Beckman Corporation, a Pennsylvania cor-poration, and Beecham Group p.l.c., an English public limited company. Its products …See details»
How SmithKline Beecham makes better resource-allocation …
Mar 1, 1998 In SB's new process, the company found an effective way to get around the all-or-nothing thinking that only reinforces the project-champion culture and allowed the organization …See details»